Houston, TX USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Novel Gene-Hunting Method Implicates New Culprit in Pancreatic Cancer

Draetta_Bronto.jpg

Using an innovative approach to identify a cancer’s genetic vulnerabilities by more swiftly analyzing human tumors transplanted into mice, researchers have identified a new potential target for pancreatic cancer treatment, published online in Cell...
23-Jun-2016 11:05 AM EDT Add to Favorites

MD Anderson to Host a National Cancer Moonshot Summit Event June 29

The University of Texas MD Anderson Cancer Center will join institutions across the country in the inaugural national Cancer Moonshot Summit, convened at the request of Vice President Joe Biden, on June 29.
21-Jun-2016 9:05 AM EDT Add to Favorites

Shorter Radiation Course Recommended for Early-Stage Breast Cancer Patients

B_Smith_bronto.jpg

Early-stage breast cancer patients receiving a shorter course of whole breast radiation with higher radiation doses per fraction reported equivalent cosmetic, functional and pain outcomes over time as those receiving a longer, lower-dose per...
15-Jun-2016 9:05 AM EDT Add to Favorites

Antibody-Based Drug Helps “Bridge” Leukemia Patients to Curative Treatment

Kantarjian_Bronto.jpg

In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic leukemia (ALL) whose disease had relapsed following standard therapies, qualified for stem cell...
10-Jun-2016 2:05 PM EDT Add to Favorites

MD Anderson and Bristol-Myers Squibb Announce New Research Collaboration in Immuno-Oncology Focused on Lung Cancer

Heymach_J_01_Bronto.jpg

Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center today announced a new clinical research collaboration to evaluate innovative strategies for the potential use of Bristol-Myers Squibb’s immuno-oncology agents...
7-Jun-2016 9:05 AM EDT Add to Favorites

Progression-Free Survival Triples in Select Metastatic Lung Cancer Patients with Surgery or Radiation After Standard Chemotherapy

Gomez_D_Bronto.jpg

Lung cancer patients with oliogometastases, defined as three or fewer sites of metastasis, may benefit from aggressive local therapy, surgery or radiation, after standard chemotherapy, according to research led by The University of Texas MD Anderson...
3-Jun-2016 3:05 PM EDT Add to Favorites

MD Anderson Researchers Highlight Advances in Gynecologic Cancer Treatments

Soliman_P_Bronto.jpg

Advances that could change gynecologic cancer standard–of-care treatments are the centerpiece of key studies being presented by researchers from The University of Texas MD Anderson Cancer Center’s Department of Gynecologic Oncology and...
3-Jun-2016 2:05 PM EDT Add to Favorites

Nivolumab Immunotherapy Helps Patients with Advanced Bladder Cancer

Sharma_P_Bronto.jpg

The immune checkpoint blockade drug nivolumab reduced tumor burden in 24.4 percent of patients with metastatic bladder cancer, regardless of whether their tumors had a biomarker related to the drug’s target, according to clinical trial results...
5-Jun-2016 9:00 AM EDT Add to Favorites

Our Experts on Newswise

Can Gender Play a Role in Determining Cancer Treatment Choices?

Liang_H_Bronto.jpg

It is well known that men and women differ in terms of cancer susceptibility, survival and mortality, but exactly why this occurs at a molecular level has been poorly understood.
9-May-2016 12:00 PM EDT

MD Anderson Study Reveals New Insight Into Tumor Progression

ZhiminLu.jpg

Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17-Aug-2015 11:00 AM EDT

Poor Survival Among Colorectal Cancer Patients Tied to Biomarker CSN6

Lee_M.jpg

A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
10-Aug-2015 12:00 PM EDT

MD Anderson Study Predicts New Hepatitis C Drugs Will Place a Dramatic Financial Strain on the Health Care System

204929_Chhatwal_Jjpg.jpg

The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by...
16-Mar-2015 6:00 PM EDT

MD Anderson Joins CATCH Global Foundation to Boost Child Health, Prevent Cancer in Later Years

Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings...
18-Feb-2015 10:00 AM EST

MD Anderson Energy Balance Expert Available for Obesity, Cancer Stories

30-Oct-2013 8:10 PM EDT

MD Anderson Obesity and Cancer Expert Researches Food Addiction

30-Oct-2013 8:00 PM EDT

The HPV Vaccine: What Have We Learned?

Expert at The University of Texas M. D. Anderson Cancer Center provide insight to parents based on what we've learned about about the HPV vaccine in the past four years.
12-Jan-2010 3:45 PM EST

Our YouTube Videos